title: Reply to Letter: "Rationale for Heating Oxaliplatin for the Intraperitoneal Treatment of Peritoneal Carcinomatosis".
authors.affiliation: Department of Surgery, Maisonneuve-Rosemont Hospital, University of Montreal, Montréal, Quebec, Canada Department of Anesthesiology, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada Department of Pathology, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada Department of Surgery, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada.
authors.forename: Lucas
authors.initials: L
authors.lastname: Sideris
authors.forename: Pierre
authors.initials: P
authors.lastname: Drolet
authors.forename: Andrew
authors.initials: A
authors.lastname: Mitchell
authors.forename: Pierre
authors.initials: P
authors.lastname: Dubé
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D002277:Carcinoma / Q000188:drug therapy* / Q000378:metabolism*; D006358:Hot Temperature; D008297:Male; D009944:Organoplatinum Compounds / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds